Fig. 2From: Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen studyBox plots showing the change in monthly migraine days (above) and HIT-6 scores (below) from baseline to weeks 9-12 of treatment with erenumabBack to article page